Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents - Test2 - elhamkhani - TriplyDB

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents

http://www.wikidata.org/entity/Q28075606

about

Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma.Extensive colorectal lymphomatous polyposis complicated by acute intestinal obstruction: a case report.Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptor β agonists toward tumor burden.Current trials for frontline therapy of mantle cell lymphoma.MicroRNAs as Biomarkers of B-cell Lymphoma

P2860

Q33802505-57332EAA-6946-4EAC-A786-4D1D54DE25C7 Q40135891-4C3628B6-9DDA-4453-8A4B-2703A088CAFD Q46775765-8138FD2D-D8DC-41A2-8B96-D4A7156D69FE Q47873950-6785A320-D2E3-4052-BE48-952B571FD0FD Q48255444-258600F1-29D4-4DFE-8199-F09AED2CAA64 Q49279565-61100499-56A1-4B29-B8CA-03726675A120 Q57814100-6FD0ECDE-BDE6-46A5-BF53-79335635F625

P2860

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents

http://www.wikidata.org/entity/Q28075606

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@ast

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@en

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@nl

type

label

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@ast

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@en

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@nl

prefLabel

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@ast

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@en

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@nl

P1433

Q28075606-1452E2EE-2408-45D2-95EF-5668E87726D8

P1476

Q28075606-6922700F-F408-4AD4-A6E7-AA61FD8733C3

P2093

Q28075606-6E495679-F87B-474E-AC85-39E68131E114

Q28075606-80697AA5-CB36-4CD1-B555-6A5F2D99C54C

Q28075606-81F04EAB-1CA7-483C-B8F2-B69CBC39EE0C

Q28075606-8D05186E-B081-4834-81F2-57A96F03E8CD

Q28075606-91D0F505-E260-47F4-9AE1-62184BB93BF5

Q28075606-A4DD80B5-87A9-43ED-B24B-379552E42FF3

Q28075606-CA6AFADB-7AD6-4D13-A647-E4440E81A303

Q28075606-E6C79518-09A2-41AB-A542-60ED4F07BF55

Q28075606-F7F7347B-25E1-4316-9056-194CF7D242DE

P275

Q28075606-19E4B9F6-1791-4AF4-B1B8-BBFB7AD61183

P2860

Q28075606-0006D5B1-3315-45A9-8B16-1DDF808433AA

Q28075606-01186D2D-D208-4476-B765-6EDA3A927AA0

Q28075606-019170CB-9C67-4DDD-989F-16E23BECFC6D

Q28075606-02FC613E-4D36-4D56-B0C4-137C5177B092

Q28075606-033D33D2-A186-44A1-BD6D-A8DFE78858FF

Q28075606-033E383C-92D4-4336-BB9A-FE148153E833

Q28075606-036C186D-42CB-492B-B874-CEE9DE5CB19C

Q28075606-04212431-FFD6-434D-9CD5-3EB4ED069B73

Q28075606-046402E4-98D6-42C0-9817-90AB6DE0B33F

Q28075606-052C2098-F7E4-49CA-9631-759ED32909BA

P304

Q28075606-A5A5CCC8-F04C-4910-9472-DD05506D7533

P31

Q28075606-B5D9EB10-CBBD-4249-8F95-2ADBF702ECFE

P3181

Q28075606-792C1989-0311-4C85-AE19-C59206D2E074

P356

Q28075606-D0AC89C3-A9E3-4766-9E24-D75E4EFAD63E

P407

Q28075606-FC6A3BB8-B85D-4897-8B36-0B2DE6572459

P433

Q28075606-31E0D732-3CC8-435E-90C9-77B04C3F9FF8

P478

Q28075606-CCBBA109-14AD-40D8-9E23-02C866A28670

P50

Q28075606-230D9661-968D-4A2B-9E0F-4F9DD92DD105

P5008

Q28075606-3BFE6DD2-A253-4671-A832-8DBBCC555093

P577

Q28075606-62D56B84-BDC4-4AE3-B942-2E1960A7081C

P698

Q28075606-09A432B6-753C-4075-B83E-5B054C30233A

P921

Q28075606-85C05B04-FEC2-45C1-9A17-D9C6696E3DFC

Q28075606-95FC25F1-EE59-4565-B05E-25F28B26F1B7

Q28075606-C9DCDD6C-9B21-4747-8731-E7A7EF3CB0F5

P932

Q28075606-78D5D1AA-CAE0-4801-BC38-00B18535E860

P3181

P356

ONCOTARGET.8961

P1433

P1476

Mantle cell lymphoma in the er ...... markers and therapeutic agents

@en

P2093

Andre Goy

http://www.w3.org/2001/XMLSchema#string

Andrew Pecora

http://www.w3.org/2001/XMLSchema#string

Arati A Inamdar

http://www.w3.org/2001/XMLSchema#string

Christen Attia

http://www.w3.org/2001/XMLSchema#string

K Stephen Suh

http://www.w3.org/2001/XMLSchema#string

Lucia Oton

http://www.w3.org/2001/XMLSchema#string

Mark Costales

http://www.w3.org/2001/XMLSchema#string

Varun Taruvai

http://www.w3.org/2001/XMLSchema#string

Yu-Ting Lin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Targeting the Checkpoint to Kill Cancer Cells

Management of mantle cell lymphoma in the elderly patient

Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma

Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains

MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.

P304

48692-48731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4885681

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.8961

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27119356

http://www.w3.org/2001/XMLSchema#string

P921

mantle cell lymphoma

local neoplasm recurrence

P932

5217048

http://www.w3.org/2001/XMLSchema#string